(22) indicated that the level of ERCC1 was statistically lower in cervical cancer tissues than that in the normal cervix tissues (P=0.025) in patients under chemoradiotherapy (cisplatin combined with radiotherapy). This evidence concerns the gene ERCC1 and cervical cancer.